Showing 3000 results
-
Press release /In the Phase IIIB APPULSE-PNH study, adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who switched to Fabhalta experienced clinically meaningful improvements in hemoglobin (Hb) levels of…
-
Event / May 30, 2025At this year’s American Society of Clinical Oncology Annual Meeting (ASCO), we will be sharing the latest oncology portfolio data, research, and science around how we are reimagining medicine.Learn…
-
Press release /Basel, May 27, 2025 - Novartis today announced that Redwood Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis (“Purchaser”), has commenced a tender offer to…
-
Featured News /
Novartis shares progress in advancing its industry-leading R&D pipeline. We are uniquely positioned to deliver transformational treatments through our scale, focus on innovative medicines, diverse range of therapeutic areas and exposure to cutting-edge platforms.